Loading stock…

Intuitive Surgical, Inc. (ISRG) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Intuitive Surgical, Inc.

ISRGMarket cap $143BPrice $404.8

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Equipment

Makes surgical robots that perform over 7 million procedures annually, from heart surgery to cancer removal. Surgeons control their da Vinci systems remotely with millimeter precision that human hands can't match.

In Bastion Portfolios?

52W Return-9%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+17%9

Revenue Forecast

Rev CAGR (1y)+17%8

Rev CAGR (3y)+15%8

Rev CAGR (5y)+12%8

Earnings Forecast

EPS Growth Y+1+39%9

EPS Growth Y+2+12%7

EPS Growth Y+3+13%7

Quality

Margins

EBIT Margin31%9

Net Income Margin28%9

Free Cash Flow Margin29%9

Debt

Net Debt/EBITDA-1.210

Efficiency

ROE17%7

ROA15%9

Earnings Stability88

GEAR+STRONG84

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)362

P/E Ratio (Forward 3y)292

P/BV7.92

EV Multiples

EV/EBITDA Fwd252

EV/EBIT Fwd292

Yield

Free Cash Flow Yield2.3%4

Dividend Yieldna–

Momentum

Short term

1 month return+10%10

3 month return-5%5

YTD return-29%1

Mid term

Price vs 52wHigh67%3

1 year return-8%4

Long term

3 year return+37%5

5 year return+20%4

Risk Shield

Price Risk

Beta1.23

Volatility37%5

Free Cash Flow

Free Cash Flow Margin29%9

Free Cash Flow Yield2.3%4

Quality

ROCE18%8

Earnings Stability88

Net Debt/EBITDA-1.210

02Growth

Is it actually growing, and how fast?

ISRGIntuitive Surgical

Revenue FY25$10.1B

GROWTH RATING↗

STRONG82 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+17%9

Revenue, next 1Y+17%8

Revenue, next 3Y, CAGR+15%8

Revenue, next 5Y, CAGR+12%8

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+39%9

EPS growth, FY27E+12%7

EPS growth, FY28E+13%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 82% of companies worldwide.

Revenue grew 17%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

Revenue is set to grow 15%/yr over the next 3 years, ahead of most of the market.8/10

Revenue grew 17%/yr over the last 3 years and is set to keep growing around 15%/yr.

The runway holds up: revenue is set to grow 12%/yr over five years.8/10

Earnings are set to grow in step with sales (EPS about 13%/yr vs revenue 15%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE41 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+10%10

3-month return-5%5

YTD return-29%1

MID & LONG-TERM▾SCORE

% of 52-week high67%3

1-year return-8%4

3-year return+37%5

5-year return+20%4

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+10%).

WATCH

Average long-term results. Multi-year returns are middling (+37% over three years and +20% over five), roughly average for the market.

Returns sit at the market level over three months (-5%).

WEAKNESSES

It's down 8% over the past year, now 33% below its 52-week high. That is a touch behind the market.

The stock is underperforming so far this year (-29%).

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the one-year trend is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Intuitive Surgical. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ISRGIntuitive Surgical

Revenue FY25$10.1B

GROWTH RATING↗

STRONG82 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+17%9

Revenue, next 1Y+17%8

Revenue, next 3Y, CAGR+15%8

Revenue, next 5Y, CAGR+12%8

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+39%9

EPS growth, FY27E+12%7

EPS growth, FY28E+13%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 82% of companies worldwide.

Revenue grew 17%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

Revenue is set to grow 15%/yr over the next 3 years, ahead of most of the market.8/10

Revenue grew 17%/yr over the last 3 years and is set to keep growing around 15%/yr.

The runway holds up: revenue is set to grow 12%/yr over five years.8/10

Earnings are set to grow in step with sales (EPS about 13%/yr vs revenue 15%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE41 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+10%10

3-month return-5%5

YTD return-29%1

MID & LONG-TERM▾SCORE

% of 52-week high67%3

1-year return-8%4

3-year return+37%5

5-year return+20%4

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+10%).

WATCH

Average long-term results. Multi-year returns are middling (+37% over three years and +20% over five), roughly average for the market.

Returns sit at the market level over three months (-5%).

WEAKNESSES

It's down 8% over the past year, now 33% below its 52-week high. That is a touch behind the market.

The stock is underperforming so far this year (-29%).

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the one-year trend is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Intuitive Surgical. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community